Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 09:41 am Sale | 2024-09-30 | 13G | Relmada Therapeutics, Inc. RLMD | Deep Track Capital, LP | 674,833 2.240% | -1,369,674 (-66.99%) | Filing History |
| 2024-03-06 4:15 pm Sale | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Perceptive Advisors LLC | 0 0.000% | -2,099,952 (Position Closed) | Filing History |
| 2024-02-14 08:53 am Sale | 2023-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Deep Track Capital, LP | 2,044,507 6.790% | -793,311 (-27.95%) | Filing History |
| 2024-02-14 07:49 am Sale | 2023-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | RTW Investments, LP | 0 0.000% | -2,067,824 (Position Closed) | Filing History |
| 2024-02-13 5:13 pm Sale | 2023-12-29 | 13G | Relmada Therapeutics, Inc. RLMD | The Vanguard Group | 1,310,805 4.350% | -206,175 (-13.59%) | Filing History |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | Relmada Therapeutics, Inc. RLMD | BlackRock Inc. BLK | 605,254 2.000% | -1,257,888 (-67.51%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,000,000 (Position Closed) | Filing History |
| 2023-02-14 4:13 pm Sale | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Point72 Asset Management, L.P. | 56,207 0.200% | -2,045,830 (-97.33%) | Filing History |
| 2023-02-14 11:56 am Sale | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -1,647,400 (Position Closed) | Filing History |
| 2023-02-14 10:10 am Sale | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | RTW Investments, LP | 2,067,824 6.900% | -118,500 (-5.42%) | Filing History |
| 2023-02-14 08:56 am Purchase | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Deep Track Capital, LP | 2,837,818 9.430% | 356,818 (+14.38%) | Filing History |
| 2023-02-14 08:14 am Sale | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Citadel Advisors LLC | 511,316 1.700% | -823,557 (-61.70%) | Filing History |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | Relmada Therapeutics, Inc. RLMD | The Vanguard Group | 1,516,980 5.040% | 1,516,980 (New Position) | Filing History |
| 2023-02-01 4:54 pm Purchase | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | BlackRock Inc. BLK | 1,863,142 6.200% | 477,907 (+34.50%) | Filing History |
| 2022-12-20 3:50 pm Purchase | 2022-12-12 | 13G | Relmada Therapeutics, Inc. RLMD | KOTLER KEVIN | 1,899,930 6.300% | 1,899,930 (New Position) | Filing History |
| 2022-10-21 4:01 pm Purchase | 2022-10-13 | 13G | Relmada Therapeutics, Inc. RLMD | Deep Track Capital, LP | 2,481,000 8.250% | 2,481,000 (New Position) | Filing History |
| 2022-10-17 4:08 pm Purchase | 2022-10-07 | 13G | Relmada Therapeutics, Inc. RLMD | Citadel Advisors LLC | 1,334,873 4.400% | 1,334,873 (New Position) | Filing History |
| 2022-10-14 9:10 pm Purchase | 2022-10-13 | 13G | Relmada Therapeutics, Inc. RLMD | Point72 Asset Management, L.P. | 2,102,037 7.300% | 2,102,037 (New Position) | Filing History |
| 2022-09-23 4:31 pm Purchase | 2022-09-16 | 13G | Relmada Therapeutics, Inc. RLMD | Perceptive Advisors LLC | 2,099,952 7.000% | 2,099,952 (New Position) | Filing History |
| 2022-02-14 4:19 pm Purchase | 2021-03-26 | 13G | Relmada Therapeutics, Inc. RLMD | Venrock Healthcare Capital Partners II L.P. | 2,270,072 8.200% | 1,601,632 (+239.61%) | Filing History |